DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Clinical trial NCT05768178 · RECRUITING

Trial details

NCT number: NCT05768178
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Haematological Malignancy Melanoma Thyroid Cancer, Papillary Ovarian Neoplasms Colorectal Neoplasms Laryngeal Neoplasms Carcinoma, Non-Small-Cell Lung Glioma Multiple Myeloma Erdheim-Chester Disease Thyroid Carcinoma, Anaplastic Solid Tumour

Start date: 2023-03-01
Primary completion: 2029-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.